Representative publications
We proudly present our research group's top journal publications!
Publications
#113. 2026 Allergy (IF, 12.0)
#114. 2026 Obes Rev (IF, 7.4)
#115. 2026 Arch Gerontol Geriatr (IF, 3.8)
#109. 2026 J Hazardous Materials (IF, 11.3)
#110. 2026 Allergy (IF, 12.0)
#111. 2026 Lancet Respir Med (IF, 32.8)
#112. 2026 J Sci Med Sport (IF, 3.4)
#105. 2025 Psy Inv (IF, 1.8)
#106. 2025 J Korean Med Sci (IF, 2.3)
#107. 2026 J Clin Neurol (IF, 3.1)
#108. 2026 Nature Medicine (IF, 50.0)
#101. 2025 J Korean Med Sci (IF, 2.3)
#102. 2025 Medicine (IF, 1.4)
#103. 2025 Lancet (IF, 88.5)
#104. 2025 Lancet Infect Dis (IF, 31.0)
#97. 2025 Int J Infect Dis (IF, 4.3)
#98. 2025 Br J Ophtalmol (IF, 3.5)
#99. 2025 Int J Gynecol Cancer (IF, 4.6)
#100. 2025 IAAI (IF, 1.8)
#93. 2025 Biomed Environ Sci (IF, 4.1)
#94. 2025 Lancet (IF, 88.5)
#95. 2025 Lancet (IF, 88.5)
#96. 2025 Lancet (IF, 88.5)
#89. 2025 Sys Rev (IF, 3.9)
#90. 2025 Gut and Liver (IF, 3.8)
#91. 2025 J Affect Disord (IF, 4.9)
#92. 2025 J Adolesc Health (IF, 4.5)
#85. 2025 Sci Rep (IF, 3.8)
#86. 2025 J Neurooncol (IF, 3.1)
#87. 2025 World Journal of Pediatrics (IF, 3.6)
#88. 2025 J Korean Med Sci (IF, 3.0)
#81. 2025 Lancet (IF, 98.4)
#82. 2025 Sci Rep (IF, 3.8)
#83. 2025 Lancet Healthy Longev (IF, 14.6)
#84. 2025 J Adv Res (IF, 13.0)
#77. 2025 EHJ (IF, 37.6)
#78. 2025 J Med Virol (IF, 6.8)
#79. 2025 J Med Virol (IF, 6.8)
#80. 2025 Eur J Clin Pharmacol (IF, 2.4)
#73. 2025 J Korean Med Sci (IF, 3.0)
#74. 2025 J Cosmet Dermatol (IF, 2.3)
#75. 2025 Sci Rep (IF, 3.8)
#76. 2025 Sci Rep (IF, 3.8)
#69. 2025 Braib Res Bull (IF, 3.5)
#70. 2025 Sci Rep (IF, 3.8)
#71. 2025 J Cachexia Sarcopenia Muscle (IF, 9.4)
#72. 2025 World Journal of Pediatrics (IF, 3.6)
#65. 2025 Scientific Reports (IF, 3.8)
#66. 2025 eClinicalMedicine (IF, 9.6)
#67. 2025 Lancet Reg Health West Pac (IF, 7.6)
#68. 2025 Clin Hypertens (IF, 2.6)
#64. 2024 Aesthetic Plast Surg (IF, 2.0)
#63. 2024 Med Princ Pract (IF, 2.9)
#62. 2024 J Korean Med Sci (IF, 3.0)
#61. 2024 Allergy Asthma Immunol Res (IF, 8.7)
#60. 2024 World J Pediatr (IF, 8.7)
#59. 2024 Heliyon (IF, 3.4)
#58. 2024 Clin Exp Allergy (IF, 6.3)
#57. 2024 Heliyon (IF, 3.4)
#56. 2024 JMIR Public Health Surveill (IF, 8.7)
#55. 2024 Pediatr Cardiol (IF, 8.7)
#54. 2024 Sci Rep (IF, 3.8)
#53. 2024 Sci Rep (IF, 3.8)
#52. 2024 Mol Psy (IF, 11.1)
#51. 2024 JMIR Public Health Surveill (IF, 3.5)
#50. 2024 Med Princ Pract (IF, 2.9)
#49. 2024 Nat Commun Biol (IF, 5.2)
#48. 2024 Int Arch Allergy Immunol (IF, 2.5)
#47. 2024 Asian J Psy (IF, 3.8)
#46. 2024 Allergy (IF, 12.6)
#45. 2024 Clin Mol Hepatol (IF, 14.0)
#44. 2024 JMIR Public Health Surveill (IF, 8.7)
#43. 2024 Int J Rheum Dis (IF, 8.7)
#42. 2024 World J Pediatr (IF, 8.7)
#41. 2024 Diabetes Obes Metab (IF, 5.4)
#40. 2024 World J Pediatr (IF, 8.7)
#39. 2024 Asian J Psy (IF, 3.8)
#38. 2024 J Med Virol (IF, 6.8)
#37. 2024 Asian J Psy (IF, 3.8)
#36. 2024 Pediatr Cardiol (IF, 1.5)
#35. 2024 Asian J Psy (IF, 3.8)
#34. 2024 Int Arch Allergy Immunol (IF, 2.5)
#33. 2024 World J Pediatr (IF, 8.7)
#32. 2024 J Med Virol (IF, 6.8)
#31. 2024 Eur J Haematol (IF, 2.3)
#30. 2024 J Med Virol (IF, 6.8)
#29. 2024 J Allergy Clin Immunol Pract (IF, 8.2)
#28. 2024 Mol Psy (IF, 11.0)
#27. 2024 JAACAP (IF, 9.2)
#26. 2024 Asian J Psy (IF, 3.5)
#25. 2024 Nat Commun (IF, 14.7)
#24. 2024 J Med Virol (IF, 6.8)
#23. 2024 J Med Internet Res (IF, 5.8)
#22. 2024 J Med Virol (IF, 6.8)
#21. 2024 Psy Res (IF, 11.3)
#20. 2024 Arch Gerontol Geriatr (IF, 3.5)
#19. 2024 Heliyon (IF, 3.4)
#18. 2024 World J Pediatr (IF, 8.7)
#17. 2024 BMJ (IF, 107.7)
#16. 2024 Sci Rep (IF, 3.8)
#15. 2024 Allergy (IF, 12.6)
#14. 2024 Front Psy (IF, 3.2)
#13. 2024 J Alzheimers Dis (IF, 3.4)
#12. 2024 Br J Dermatol (IF, 11.1)
#11. 2024 Int Arch Allergy Immunol (IF, 2.8)
#10. 2024 J Sleep Res (IF, 4.4)
#9. 2024 J Adv Res (IF, 11.4)
#8. 2024 Br J Dermatol (IF, 11.1)
#7. 2023 Chronobio Int (IF, 2.8)
#6. 2023 Asian J Psy (IF, 9.5)
#5. 2023 Psy Res (IF, 11.3)
#4. 2023 Front Endocrinol (IF, 5.2)
#3. 2022 Biomedicines (IF, 4.7)
#2. 2022 J Pers Med (IF, 3.5)
#1. 2020 Nutrients (IF, 5.9)